help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MATUSCHAK, G. M.
Right arrow Articles by LECHNER, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MATUSCHAK, G. M.
Right arrow Articles by LECHNER, A. J.

Am. J. Respir. Crit. Care Med., Volume 163, Number 4, March 2001, 1002-1009

Liver-Lung Interactions Following Escherichia coli Bacteremic Sepsis and Secondary Hepatic Ischemia/Reperfusion Injury

GEORGE M. MATUSCHAK, KURT A. HENRY, CHERYL A. JOHANNS, and ANDREW J. LECHNER

Division of Pulmonary, Critical Care, and Occupational Medicine, Department of Internal Medicine, and Department of Pharmacological and Physiological Science, Saint Louis University Health Sciences Center, St. Louis, Missouri; and Department of Critical Care Medicine, Saint John's Mercy Medical Center, St. Louis, Missouri

We hypothesized that ischemia/reperfusion (I/R) injury of the liver during normotensive gram-negative bacteremic sepsis alters the kinetics of circulating endotoxin, tumor necrosis factor-alpha (TNF-alpha ), and coinduced mediators, thereby exacerbating sepsis-induced lung inflammation. Liver and lung dysfunction were studied after hematogenous infection of Sprague-Dawley rats with 109 Escherichia coli serotype O55:B5 (EC) and 90 min of secondary hepatic ischemia in EC + I/R and saline-infused (normal saline NS) × I/R rats, followed by brief (1 h) or longer reperfusion (24 h). TNF- alpha :leukotriene interactions in this model were examined using the 5-lipoxygenase-activating protein inhibitor MK-886. Compared with sham-operated EC + Sham animals, peak serum endotoxin, TNF-alpha , alanine aminotransferase, interleukin-6 (IL-6), and hepatic neutrophil (PMN) influx were higher in EC + I/R rats through 24 h (p < 0.05) despite comparable arterial pressure. Lung PMN influx and wet/dry weight ratios were likewise enhanced in EC + I/R versus EC + Sham or NS + I/R rats. MK-886 attenuated TNF-alpha concentrations and ischemic liver injury but not mortality. Thus, focal hepatic I/R augments circulating endotoxin, TNF-alpha , and postbacteremic lung inflammation early after normotensive E. coli bacteremic sepsis.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Ota, K. Nakamura, T. Yazawa, Y. Kawaguchi, Y. Baba, R. Kitaoka, N. Morimura, T. Goto, Y. Yamada, and K. Kurahashi
High tidal volume ventilation induces lung injury after hepatic ischemia-reperfusion
Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L625 - L631.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. M. Siore, R. E. Parker, A. A. Stecenko, C. Cuppels, M. McKean, B. W. Christman, R. Cruz-Gervis, and K. L. Brigham
Endotoxin-induced acute lung injury requires interaction with the liver
Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L769 - L776.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. E. Sewnath, T. van der Poll, C. J. F. van Noorden, F. J. W. ten Kate, and D. J. Gouma
Cholestatic Interleukin-6-Deficient Mice Succumb to Endotoxin-induced Liver Injury and Pulmonary Inflammation
Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 413 - 420.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. P. James, S. S. McCullough, L. W. Lamps, and J. A. Hinson
Effect of N-Acetylcysteine on Acetaminophen Toxicity in Mice: Relationship to Reactive Nitrogen and Cytokine Formation
Toxicol. Sci., October 1, 2003; 75(2): 458 - 467.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Critical Care Medicine in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 565 - 583.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society